Results

Turning Point Therapeutics Inc.

04/05/2021 | Press release | Distributed by Public on 04/05/2021 14:03

Turning Point Therapeutics Announces Initial Clinical Data From Phase 1/2 SWORD-1 Study of RET Inhibitor TPX-0046